Search research articles
Contact Us
Filters
Showing results (121-130 of 154) with videos related to
Page
of 16
Sort By:
Molecular Cancer Therapeutics
|
September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo
Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
Cancer Metastasis Reviews
|
April 2, 2022
Connecting the Human Microbiome and Pancreatic Cancer
Rachel E Sexton, Md Hafiz Uddin, Sahar Bannoura, et al.
Frontiers in Pharmacology
|
February 21, 2024
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection
Abdelrahim Maen, Betul Gok Yavuz, Yehia I Mohamed, et al.
Cancers
|
December 5, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors
Gabriel Mpilla, Amro Aboukameel, Irfana Muqbil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
Asfar S Azmi, Husain Yar Khan, Irfana Muqbil, et al.
Cancers
|
April 3, 2020
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth
Husain Yar Khan, Gabriel B Mpilla, Rachel Sexton, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in <i>KMT2A</i> r and <i>NPM1</i> -m AML
Md Hafiz Uddin, Sandhya Dhiman, Yufen Han, et al.
JCO Oncology Advances
|
May 7, 2025
Multiomic Characterization of <i>RCC1</i> and <i>RCC2</i> Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes
Misako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, et al.
Cancer Research Communications
|
May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers
Husain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
JCO Precision Oncology
|
October 24, 2024
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma
Gianna Kroening, Jia Luo, Mark G Evans, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 154) with videos related to
Sort By:
Page
of 16
Molecular Cancer Therapeutics
|
September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo
Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
Cancer Metastasis Reviews
|
April 2, 2022
Connecting the Human Microbiome and Pancreatic Cancer
Rachel E Sexton, Md Hafiz Uddin, Sahar Bannoura, et al.
Frontiers in Pharmacology
|
February 21, 2024
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection
Abdelrahim Maen, Betul Gok Yavuz, Yehia I Mohamed, et al.
Cancers
|
December 5, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors
Gabriel Mpilla, Amro Aboukameel, Irfana Muqbil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
Asfar S Azmi, Husain Yar Khan, Irfana Muqbil, et al.
Cancers
|
April 3, 2020
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth
Husain Yar Khan, Gabriel B Mpilla, Rachel Sexton, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in <i>KMT2A</i> r and <i>NPM1</i> -m AML
Md Hafiz Uddin, Sandhya Dhiman, Yufen Han, et al.
JCO Oncology Advances
|
May 7, 2025
Multiomic Characterization of <i>RCC1</i> and <i>RCC2</i> Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes
Misako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, et al.
Cancer Research Communications
|
May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers
Husain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
JCO Precision Oncology
|
October 24, 2024
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma
Gianna Kroening, Jia Luo, Mark G Evans, et al.
Page
of 16